The mutation of EGFR is the major factor associated with non-small cell lung carcinoma (NSCLC), in addition to a frequent mutation of KRAS and fusion of anaplastic lymphoma kinase (ALK) [157]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.